Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer.

Crawford, E David

Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer. [electronic resource] - The Canadian journal of urology Dec 2015 - 8048-55 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1195-9479


Antineoplastic Agents--administration & dosage
Clinical Trials as Topic
Humans
Immunotherapy
Male
Neoplasm Metastasis
Prostatic Neoplasms, Castration-Resistant--drug therapy
Time Factors
Tissue Extracts--administration & dosage
Tumor Burden